video
HIV/AIDS: Progress and Promise in Stem Cell Research
CIRM has funded two HIV/AIDS Disease Teams led by scientists at UCLA and the City of Hope who are focused on stem cell transplant strategies that promise a long lasting resistance to HIV. Antiretroviral therapy provides life-saving medicine to HIV-infected people but it is not a cure. Long-term exposure to the drugs and the virus itself shorten a person’s life, even if they don’t develop AIDS. Both disease teams have a goal of getting to clinical trials within four years. For more info, go to: www.cirm.ca.gov/HIV/AIDS_facts
The Promising Cells Presented by International Stem Cell Corporation
Ken Aldrich of International Stem Cell Corporation (ISCO.OB) speaks on the latest research involving stem cell technology utilizing unfertilized eggs, as a basis for cell generation with a goal toward organ transplants which are immune to rejection by the body.
See complete article at the International Stem Cell Corporation blog
Red blood cells made from stem cells successfully injected into patient
French researchers have successfully injected red blood cells produced from stem cells into a patient. It’s the first time this has happened. Click here for full article.
New stem cell trial study could redefine stroke treatment
A month ago, a 39-year-old single mother from Hawthorne suffered a severe stroke that left her unable to walk.
Paramedics took her to a designated hospital stroke center. To preserve her brain function, doctors treated her with clot-busting drugs and asked her if she would be the first to participate in a clinical trial involving stem cells
See complete article at abclocal.go.com
Adult stem cells effective against clogged leg arteries
At its worst, clogged leg arteries can cause dangerous complications like severe pain, gangrene, even loss of limbs. It’s treated with lifestyle changes, exercise and medications to surgical interventions.
Now for patients with the most serious blockages, researchers are studying an experimental option: adult stem cells.
Read entire article at ABCLocal.go.com.
Stem Cell Banking: The Perspective of an iPS Donor Family
“Your twin daughters have an extremely rare, fatal disease called Niemann Pick Type C and there’s nothing you can do for them”. Those were the devastating words that Chris Hempel and her husband first heard in 2007. Rather than just give in to this fate, the Hempels are proactively engaging researchers to try to save Addi and Cassi’s lives. This journey includes donating skin samples to cell banks so that researchers can create induced pluripotent stem (iPS) cells, a promising technology which may help undercover treatments for their daughters. In this video, Chris Hempel speaks to the CIRM Standards Working Group to present a patient advocate’s perspective on the challenges of rare disease research. Hempel was introduced by CIRM Governing Board member, Sherry Lansing.
For more information about the Hempels and Niemann Pick Type C, visit: http://addiandcassi.com/
Successful stem cell therapy for COPD
For more information see this additional video, Lung Disease and COPD
Cardiovascular Therapies: Spotlight on Stem Cell Research
“Welcoming Remarks” (Part 1 of a 4-part series)
Robert Klein, J.D. and Claire Pomeroy, M.D., M.B.A., gave the welcoming remarks for the “Spotlight on Cardiovascular Therapies,” an educational event presented at the California Institute for Regenerative Medicine Governing Board meeting on March 10, 2011 in Burlingame, CA.
Klein is Chair of the CIRM Governing Board. Pomeroy is Vice Chancellor for Human Health Sciences at UC Davis and Dean of the UC Davis School of Medicine.
The entire series can be found at http://www.youtube.com/user/CIRMTV
The California Institute for Regenerative Medicine, the state stem cell agency, funds adult and embryonic stem cell research at institutions and for-profit organizations in California. These funds are accelerating a field of research that holds the possibility of bringing new therapies for debilitating diseases.
Adult Stem Cells for Treatment of Rheumatoid Arthritis
Dr. Thomas Ichim and Dr. Bob Harman discuss use of fat stem cells for treatment of rheumatoid arthritis. These two recently published a paper on this as part of a Medistem/Vet-Stem collaboration.
About Medistem Inc.
Medistem Inc. is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases. The company’s lead product, the endometrial regenerative cell (ERC), is a “universal donor” stem cell being developed for critical limb ischemia. For more informarion visit website: http://www.medisteminc.com/
About Vet-Stem
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine technology to the veterinary profession. Our goal is to be the conduit for the latest developments in human medical technology and provide easy-to-use services and products to the practicing veterinarian. For more information visit website: http://www.vet-stem.com/
Stem Cells: the Hope, the Hype and the Science
UCSF’s Osher Center for Integrative Medicine presents Stem Cells and Regenerative Medicine: The science behind emerging treatment advances and personalized medicine.
